After Alzheimer’s disease, Parkinson’s disease is currently the second most common neurodegenerative disease. The majority of those affected are ≥60 years old when it first manifests, but a minority develop the disease at a younger age. With suitable symptomatic therapies, the disease can often be well controlled for years. Consideration of the individual symptom profile is crucial here. A causal therapy does not yet exist, but disease-modifying approaches are being researched.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Diabetes mellitus
Treatment of comorbidities in older people
- Liver steatosis with metabolic dysfunction
New nomenclature for non-alcoholic fatty liver disease
- Type 2 diabetes: PAD and diabetic foot syndrome
Prevention is better than cure – don’t miss the risk foot
- Prostate cancer
High-resolution ultrasound could diagnose prostate cancer faster
- Chronic lung diseases
Sarcopenia and malnutrition in the context of pneumological rehabilitation
- Psychooncology
Communication as the key to therapy adherence
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- From symptom to diagnosis